Date: {{$ActivityAssignDate}}

Dear {{$doctorName}},


Subject: {{$ActivityName}}


Sporidex CV is an orally administered fixed dose combination of specifically designed extended release formulation of cephalexin and clavulanic acid. Cephalexin is indicated for the treatment of infections of the upper and lower respiratory tract, genitourinary system, skin and soft tissue, bones and joints, dental infections and certain other infections due to susceptible organisms.


Sporidex CV (Cephalexin extended release 375/750 and Clavulanic acid 125) tablets are marketed by the ‘Classic’ team of Sun Pharmaceutical Industries Ltd.


Although every product is marketed only after regulatory approval, it is important to know how it performs in day-to-day practice of individual medical practitioners. For this purpose, we have planned to conduct a prospective study to assess the real-life performance of ‘Sporidex CV’ in patients.


We invite you to participate in this study. All you need to do is to report on a standard form your experience with ‘Sporidex CV’ in {{$numberOfPatient}} consecutive patients in whom you prescribe this product in the normal course of your practice. Thus, this is not an experimental study because the product will be prescribed and purchased as you and your patients normally do.


If you agree to participate, you will need to copy the relevant information from the suggested number of patient’s case papers on to the standard case report forms. Let us assure you that the CRF will not contain the patients’ names, so as to ensure confidentiality. If any serious adverse events (AE) occur during ‘Sporidex CV therapy, you will be expected to report them to us immediately on the AE reporting form.

As you will be spending some extra time to keep, copy and verify these patient’s records, we offer to pay you by cheque a professional fee of Rs. {{$contractAmount}}/- .


We trust you and we are partners in promoting safe and effective drug therapy. In that spirit, we hope you will consent to participate in this study. If you do, please sign and return the enclosed reply along with your visiting card for accuracy of records.







Yours truly,

Mr. Kunal Banodkar
Sun Pharmaceutical Industries Ltd.
Sun House CTS No. 201 B/1,
Western Express Highway,
Goregaon (E),
Mumbai - 400 063
Tel: + 91 22 4324 1234/4324